Hologic (HOLX) Tops Q2 EPS by 47c; Offers FY22 Guidance

Hologic (NASDAQ: HOLX) reported Q2 EPS of $2.07, $0.47 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.29 billion.

GUIDANCE:

Hologic sees FY2022 EPS of $5.45-$5.65, versus the consensus of $5.15. Hologic sees FY2022 revenue of $4.6-4.7 billion, versus the consensus of $4.53 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Pinduoduo (PDD) Tops Q2 EPS by 98c
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook